Fluoxetine News
Sertraline and fluoxetine: Safe treatments for children and adolescents with epilepsy and depression
Objective: Depression is frequent, underdiagnosed, and untreated in people with epilepsy. The lack of treatment is partially explained by the concerns over the proconvulsive effects of psychoactive drugs. There are few studies on...
Failed Efficacy of Fluoxetine in the Treatment of Posttraumatic Stress Disorder: Results of a Fixed-Dose, Placebo-Controlled Study
A multicenter, double-blind, 12-week, placebo-controlled trial of 411 randomized patients, predominantly women diagnosed with posttraumatic stress disorder, failed to show a difference between either dose of fluoxetine treatment...
Prozac use in children
The licence for Prozac (fluoxetine) has been extended to include the treatment of moderate to severe major depressive episodes in children aged eight and above.
Does Fluoxetine Have Any Effect on the Cognition of Patients With Mild Cognitive Impairment?: A Double-Blind, Placebo-Controlled, Clinical Trial.
Objectives: Mild cognitive impairment (MCI) may be a prodromal state for Alzheimer disease. Recent research suggest a role for other neuronal systems such as monoaminergic hypofunction beside cholinergic dysfunction in...
A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, and fluoxetine in treatment-resistant major depressive disorder
OBJECTIVE: Two parallel, 8-week double-blind studies compared olanzapine/fluoxetine combination, olanzapine, and fluoxetine in outpatients with treatment-resistant depression (TRD).